Spherocytosis type 2
Common Name(s)
Spherocytosis type 2
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Spherocytosis type 2" for support, advocacy or research.
Our goal is to assist families of HS {SPHEROCYTOSIS, type 1 to 5} patients and to promote effective SPHEROCYTOSIS research. Additionally, we want to establish an HS Foundation.
How do you compare to others with this condition?
Privately answer questions about your health. Let resources, you select, come to you.
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Advocacy and Support Organizations
Condition Specific Organizations
Following organizations serve the condition "Spherocytosis type 2" for support, advocacy or research.
Our goal is to assist families of HS {SPHEROCYTOSIS, type 1 to 5} patients and to promote effective SPHEROCYTOSIS research. Additionally, we want to establish an HS Foundation.
Recommended Apps
Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.
Finding the right clinical trial for Spherocytosis type 2 can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.
Scientific Literature
Articles from the PubMed Database
Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Spherocytosis type 2" returned 0 free, full-text research articles on human participants.
No free, full-text research articles on human participants are available at this time. Please click this link to visit the PubMed website for results on "Spherocytosis type 2".
Reviews from the PubMed Database
Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Spherocytosis type 2" returned 0 free, full-text review articles on human participants.
No free, full-text review articles on human participants are available at this time. Please click this link to visit the PubMed website for results on "Spherocytosis type 2".
Symptoms, Diagnosis, and Treatment
https://ghr.nlm.nih.gov/gene/SPTB
https://ghr.nlm.nih.gov/gene/SPTA1
https://ghr.nlm.nih.gov/condition/type-2-diabetes
https://ghr.nlm.nih.gov/condition/atelosteogenesis-type-2
https://ghr.nlm.nih.gov/condition/spinocerebellar-ataxia-type-2
https://ghr.nlm.nih.gov/condition/spastic-paraplegia-type-2
https://ghr.nlm.nih.gov/condition/neurofibromatosis-type-2
https://ghr.nlm.nih.gov/condition/otopalatodigital-syndrome-type-2
https://ghr.nlm.nih.gov/condition/pseudohypoaldosteronism-type-2
https://ghr.nlm.nih.gov/chromosome/2
https://ghr.nlm.nih.gov/condition/2-hydroxyglutaric-aciduria
https://ghr.nlm.nih.gov/gene/NKX3-2
https://ghr.nlm.nih.gov/condition/distal-myopathy-2
https://ghr.nlm.nih.gov/condition/congenital-bile-acid-synthesis-defect-type-2
https://ghr.nlm.nih.gov/gene/ANK1
https://ghr.nlm.nih.gov/condition/adenosine-deaminase-2-deficiency
https://ghr.nlm.nih.gov/gene/SLC4A1
https://ghr.nlm.nih.gov/gene/D2HGDH
https://ghr.nlm.nih.gov/condition/complement-component-2-deficiency
There are currently no related results available in GeneReviews.
Clinical Trial Information This information is provided by ClinicalTrials.gov
There are currently no open clinical trials for this condition.
Finding the right clinical trial for Spherocytosis type 2 can be challenging. However, with TrialsFinder (which uses the Reg4ALL database and privacy controls by Private Access), you can permit researchers to let you know opportunities to consider - all without revealing your identity.